GeneDx Holdings WGS
NASDAQ WGS
$101.10 -3.85 (-3.67%)
At close: Sep 18, 2026 · 4:00 PM EDT

GeneDx Holdings (WGS) Treasury Shares (2020 - 2021)

GeneDx Holdings' (WGS) quarterly Treasury Shares came in at $171.5 million in Q2 2021, up 16.66% year-over-year from $147.0 million in Q2 2020, and little changed quarter-over-quarter from $171.5 million in Q1 2021.

Analysis

GeneDx Holdings (WGS) Treasury Shares (2020 - 2021) Analysis & Trends

GeneDx Holdings (WGS) has reported Treasury Shares for 2 consecutive years, with $171.5 million the latest figure, recorded in Q2 2021.

  • On a quarterly basis, Treasury Shares rose 16.66% year-over-year to $171.5 million in Q2 2021; TTM through Jun 2021 was $171.5 million, a 16.66% increase from a year earlier, with the FY2020 full-year figure at $171.5 million, up 16.66% from the prior year.
  • Treasury Shares was $171.5 million for Q2 2021 at GeneDx Holdings, roughly flat from $171.5 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $171.5 million in Q3 2020 and troughed at $147.0 million in Q2 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn -
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn 52.00 Mn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn -
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn -
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn 183,229.00
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn -
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn 675,000.00
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn -
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn -
10 GeneDx Holdings 3.01 Bn 2.88 Bn 78.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 171.54 Mn
Jun 30, 2021 171.54 Mn
Mar 31, 2021 171.54 Mn
Mar 31, 2021 171.54 Mn
Dec 31, 2020 171.54 Mn
Dec 31, 2020 171.54 Mn
Sep 30, 2020 171.54 Mn
Sep 30, 2020 171.54 Mn
Jun 30, 2020 147.04 Mn
Jun 30, 2020 147.04 Mn